Immune checkpoint inhibitors in GBM

ConclusionsDespite the positive impact of immune checkpoint inhibitors in many cancers, only a small subset of GBM patients respond to these agents. Further research is needed to identify biomarkers of response and therapies to rationally combine with immune checkpoint inhibitors.
Source: Journal of Neuro-Oncology - Category: Cancer & Oncology Source Type: research